Subsequently, this research team conducted a prospective study in 70 NSCLC patients treated with ICIs, indicating that HPD was closely associated with dysfunctional CD4 immunity and an increased number of peripheral CD28− CD4+ T cells (48). This evidence concerns the gene CD4 and non-small cell lung carcinoma.